Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Journal of lipid research - 1 Dec 2003

Olivieri Oliviero, Bassi Antonella, Stranieri Chiara, Trabetti Elisabetta, Martinelli Nicola, Pizzolo Francesca, Girelli Domenico, Friso Simonetta, Pignatti Pier Franco, Corrocher Roberto

Abstract excerpt

Apolipoprotein C-III (apoC-III) is a marker of triglyceride (TG)-rich lipoproteins, which are often increased in metabolic syndrome (MS). The T-455C polymorphism in the insulin-responsive element of the APOC3 gene influences TG and apoC-III levels. To evaluate the contribution of apoC-III levels and T-455C polymorphisms in the coronary artery disease (CAD) risk of MS patients, we studied 873 patients, 549 with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Apolipoprotein C-III

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins C

Share to Data Interpretation, Statistical

Share to Lipids

Share to Metabolic Syndrome

Share to Odds Ratio

Share to Substrate Specificity

Source

Identifiers

PMID: 14563827
DOI: 10.1194/jlr.M300253-JLR200

Genes

CAD
APOC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.PMID 14563827Read ↗

[An Association Between T455C Polymorphism of Apolipoprotein C-III Gene, Insulin Resistance and Metabolic Syndrome Components].Semantic proximity Read ↗

Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.Semantic proximity Read ↗

Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.Semantic proximity Read ↗

Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population.Semantic proximity Read ↗

Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.Semantic proximity Read ↗

ApoC-III gene polymorphisms and risk of coronary artery disease.Semantic proximity Read ↗

Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management.Semantic proximity Read ↗

Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians.Semantic proximity Read ↗

Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.Semantic proximity Read ↗

Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.Semantic proximity Read ↗

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.Semantic proximity Read ↗

Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.